Position in DHR
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$459,628
+$201,627 QoQ
Shares Held
2,413
+160.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,402
of 2,098 holders
Holding Since
Dec 2023
5 quarters on record
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026SNS Financial Group, LLC holds $5,135,597 across 7 Diagnostics & Research names. DHR ranks #4 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
3,764 | $1,887,119 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
7,708 | $1,489,339 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
1,293 | $680,686 | |
| 4 | DHR |
Danaher Corp /De/
This page
|
2,413 | $459,628 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
949 | $215,223 | |
| 6 | WAT |
Waters Corp /De/
|
541 | $202,896 | |
| 7 | A |
Agilent Technologies, Inc.
|
1,511 | $200,706 |
All Filings in DHR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $459,628 | 2,413 | Shares | Sole | 2026-08-11 | |
| 2024-09-30 | $258,001 | 928 | Shares | Defined | 2024-11-01 | |
| 2024-06-30 | $234,858 | 940 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $236,733 | 948 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $216,070 | 934 | Shares | Sole | 2024-01-22 | |
| No filing history on record for this holder in this stock. | ||||||